Mundipharma associate launches Remsima in UK and preps for wider roll out
Mundipharma’s associate Napp Pharmaceuticals launched Celltrion’s Remicade biosimilar Remisma in the UK today, just 24 hours after the originator lost patent protection.
Archives for February 25, 2015
Shire steps further into rare diseases with $70m acquisition
Shire has acquired privately-held Meritage for an upfront fee of $70m and additional contingent payments based on the achievement of development and regulatory milestones.
UK gives $31m to industry-academic biodevelopment collabs
The UK has granted £20m ($31m) to the biotech industry – including Horizon, FujiFilm, and Cobra Biologics, to bring mAb, cell expression, and antibiotic projects to market.